13G filed by BCLS Fund III Investments, LP
BCLS Fund III Investments, LP reported 6,728,970 shares of ADARx Pharmaceuticals, Inc., 6.3% of the class, as of 2026-09-24, in a 13G accepted by EDGAR 2026-10-01 20:00:02 UTC.
- Accession
- 0001193125-26-410626
- Filer
- CIK 1952107
- Filed
- 2026-10-01
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Subject
- ADARx Pharmaceuticals, Inc.
- Shares
- 6,728,970
- Percent of class
- 6.3%
- Event date
- 2026-09-24
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Read for the filer group BCLS II Investco, LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| BCLS Fund III Investments, LP | PN | 0 | 6,728,970 | 0 | 6,728,970 | 6,728,970 | 6.3% |